Diagnostics & biomarkers

Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker

Duchenne Evidence Moves Into the Muscle

Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems

Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy

KRAS Has a New Contender. It Still Has to Earn Its Place.

Cyclospora Is Spreading. The Food Chain Still Has No Answer.

China’s Biliary-Cancer Bet Has a Global Access Problem

Alzheimer’s Trials Are Finally Blood-Gated

ALS Needs Proof, Not Just Another Biomarker
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
